About the Product

Description


Furotide 10 Injection containing Furosemide 10 mg/ml is a potent diuretic used for rapid removal of excess fluid from the body. It helps in managing edema, controlling blood pressure, and relieving symptoms associated with fluid overload in cardiac, renal, and hepatic conditions.

Furosemide works by acting on the kidneys to increase urine output, promoting the excretion of sodium, chloride, and water. This mechanism helps reduce fluid accumulation and lowers pressure on the heart and blood vessels.

The injection provides quick and effective action, making it suitable for emergency and hospital settings where immediate diuresis is required. It is widely used in conditions such as pulmonary edema and acute heart failure.

With increasing cases of cardiovascular and renal disorders, this product has strong demand in hospital and critical care segments. Its rapid action, high clinical utility, and consistent usage make it a valuable addition for expanding presence and driving growth in the cardiac care range.

Some patients may experience dehydration, electrolyte imbalance (such as low potassium), dizziness, hypotension, or increased urination. Rarely, hearing disturbances, severe electrolyte imbalance, or allergic reactions may occur and require immediate medical attention.

Furotide 10 Injection is indicated for the treatment of edema associated with congestive heart failure, liver cirrhosis, and kidney disorders. It is also used in the management of acute pulmonary edema and hypertension. It helps remove excess fluid, relieve swelling, and improve breathing and overall cardiovascular function.

This injection should be administered under strict medical supervision. Monitoring of electrolyte levels, kidney function, and blood pressure is essential during treatment. Patients should be cautious about dehydration and maintain adequate fluid intake as advised by their healthcare provider.

Store in a cool, dry place below 25°C, protected from light. Do not freeze. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Frusemide IP 20mg Injection in the PCD pharma franchise market?

Frusemide IP 20mg Injection has strong demand in the critical care, cardiology, nephrology, emergency medicine, and hospital care segment, making it a valuable product for medical distributors, institutional suppliers, and pharma franchise partners serving hospitals and specialty healthcare facilities.

Why should medical distributors include Frusemide IP 20mg Injection in their product range?

Medical distributors and agencies can benefit from demand for emergency fluid management and cardiovascular care under medical supervision. Frusemide IP 20mg Injection is a loop diuretic widely used in hospital and emergency care settings Commonly administered for the management of acute pulmonary edema, fluid overload, congestive heart failure, hypertension, and edema associated with renal or hepatic disorders as advised by healthcare professionals Helps remove excess fluid from the body by increasing urine output and reducing fluid retention Injectable formulation allows rapid onset of action, making it suitable for emergency and critical care situations Requires administration and monitoring by qualified healthcare professionals to ensure safe and effective treatment Frequently utilized in intensive care units (ICUs), emergency departments, cardiology units, nephrology centers, and hospitals Widely used by cardiologists, nephrologists, intensivists, emergency medicine specialists, and general physicians This strengthens a comprehensive critical care and hospital product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Frusemide IP 20mg Injection with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers, institutional suppliers, and medical agencies benefit from consistent hospital demand, repeat procurement requirements, reliable supply chain support, specialty healthcare market opportunities, and attractive margins in the critical care segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, wholesalers, and institutional suppliers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.